No abstract available
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Captopril / therapeutic use
-
Coronary Disease / complications*
-
Coronary Disease / drug therapy
-
Coronary Disease / physiopathology
-
Female
-
Heart / physiopathology
-
Heart Failure / etiology*
-
Heart Failure / physiopathology
-
Heart Failure / prevention & control
-
Humans
-
Male
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Myocardial Infarction / complications
-
Myocardial Infarction / drug therapy
-
Randomized Controlled Trials as Topic
-
Spironolactone / therapeutic use
-
Ventricular Dysfunction, Left / drug therapy
-
Ventricular Dysfunction, Left / etiology*
-
Ventricular Dysfunction, Left / physiopathology
-
Ventricular Remodeling*
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Mineralocorticoid Receptor Antagonists
-
Spironolactone
-
Captopril